& medical supplies
Totabl Debt to Equity 0.13 0.25 * based on only cost of medicine & medical supplies
%. The growth was mainly contributed from Property, Plant and Equipment and other assets. PP&E increased due to investment in MRI and Hemodialysis Centers, purchasing Medical Devices and Equipment and
quarters ** based on only cost of medicine & medical supplies
six-month period ended June 30, 2019. The period-on-period increase in finance costs was because of a loan withdrawal to construction disbursement and purchasing medical equipment. Net profits The
medicine & medical supplies
purchasing medical equipment. Net profits The Company booked net profits of Baht 45.17 million and Baht 74.45 million in the nine- month period ended September 30, 2018 and the nine-month period ended
COMPANY LIMITED AMARC: ASIA MEDICAL AND AGRICULTURAL LABORATORY AND RESEARCH CENTER PUBLIC COMPANY LIMITED AMARIN: AMARIN CORPORATIONS PUBLIC COMPANY LIMITED AMATA: AMATA CORPORATION PUBLIC COMPANY LIMITED
-2 Ranking ASIA ASIA HOTEL PUBLIC COMPANY LIMITED Filing FinancialStatement 56-1 56-2 Ranking AMARC ASIA MEDICAL AND AGRICULTURAL LABORATORY AND RESEARCH CENTER PUBLIC COMPANY LIMITED Filing